‚Äč

SYMPOSIUM 37


08.00-09.30    HALL A

Novel oral anticoagulants or warfarin in CKD?

Chairs: Mustafa Arici, Ankara, Turkey
             Emanuel Zitt, Feldkirch, Austria

Is chronic anticoagulation treatment needed in chronic kidney disease?
Adrian Covic, Iasi, Romania
Do novel oral anticoagulants differ from vitamin K antagonists for efficacy or bleeding?
Jürgen Floege, Aachen, Germany
Novel oral anticoagulants or warfarin in CKD - a cardiologists perspective
Karolina Szummer, Stockholm, Sweden

back to the timetable

final programme "day by day" - may 21 - 24, 2016

today